Cite
HARVARD Citation
Dahl, R. et al. (n.d.). P150 Once-daily tiotropium Respimat® reduces risk of severe asthma exacerbation and asthma worsening in symptomatic asthma, independent of allergic and inflammatory status. Thorax. p. A152. [Online].